CERE Cerevel Therapeutics Inc Total Business Assets
Cerevel Therapeutics (CERE) develops innovative treatments for brain pathologies by utilizing targeted receptor action to reduce side effects. Entry into this niche is restricted by strict FDA oversight and exclusive patents. The price history of total assets, valued at 1028.75, is presented below. The business operates within the safe haven of the US jurisdiction, remaining insulated from global trade conflicts.
Analytical breakdowns and data insights for company Cerevel (CERE)
- stock value and consensus price forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Cerevel Therapeutics|CERE - Long-Term Debt to Equity|Current Liabilities to Capital Cerevel Corp|CERE - Company Aggregate Debts|Debt to Book Value Cerevel Corp|CERE - Company Long-Term Debts|Short-Term Debt Cerevel Therapeutics|Intermediate Coverage Ratio cerevel.com
- company profitability and valuation multiples indicators:
Fundamental valuation:CERE, cerevel.com
A reverse calculation via ROA makes this indicator sensitive to profit and capital dynamics, measuring the aggregate of resources and liabilities to assess financial stability. For Cerevel Therapeutics, which invests in neurobiology to combat CNS diseases, the organization's asset value reflects the scale of the material base required to develop complex drugs, allowing investors to differentiate real growth from speculative movement.
Direct competitors
Company Assets biogen.com (BIIB)|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Company Total Assets|Cumulative Company Assets amylyx.com (AMLX)|Company Total Assets TRVI|PRAX - Company Assets|Aggregate Company Assets Anavex Corp AVXL|Aggregate Asset Value CBLL|Prothena Corporation plc - Company Total Assets|Company Assets Alector, Inc.|ANNX (Annexon) - Cumulative Company Assets|OMER (Omeros) - Aggregate Company Assets|NGNE (Neurogene Corp) - Company Total Assets|Company Assets AC Immune Inc ACIU|Aggregate Company Assets Voyager Therapeutics (VYGR)|Aggregate Company Assets NMRA (neumoratx.com)|Scilex - Cumulative Company Assets|Aggregate Asset Value TVGN|ACOG: Cumulative Company Assets|Cognition Therapeutics Inc. - Aggregate Business Assets|IKT: Company Total Assets|cassavasciences.com - Aggregate Asset Value|ASRT (Assertio Holdings) - Company Total Assets|Company Assets Coya COYA|Aggregate Company Assets Vistagen Therapeutics (VTGN)|OVID (ovidrx.com) - Aggregate Asset Value|Company Total Assets ABOS (Acumen Pharmaceuticals)|Company Total Assets cervomed.com CRVO|ATHE - Aggregate Company Assets|Total Asset Value of Company CLNN|PEPG: Company Total Assets|Company Assets Jupiter Neurosciences, Inc. (JUNS)|Cumulative Company Assets RLMD|Company Total Assets annovisbio.com|Cumulative Company Assets GRCE (Grace Therapeutics, Inc.)|Aggregate Business Assets AIFF|Company Total Assets KLTO (Klotho Neurosciences)|Company Total Asset Base NeuroSense Therapeutics Ltd (NRSN)|Reviva Pharmaceuticals - Company Total Assets|MetaVia Inc (MTVA) - Cumulative Company Assets|NeurAxis (NRXS) - Aggregate Company Assets|HSDT - Company Total Asset Base|PASG (Passage Bio Inc.) - Company Total Assets|Cumulative Company Assets Neuphoria (NEUP)|Company Total Assets NERV|ATHA - Company Assets|Aggregate Company Assets Addex Therapeutics Ltd ADXN|Aggregate Asset Value ALZN|Cyclerion - Company Total Assets|Company Assets Protagenic Therapeutics|pasitheaclinics.com (KTTA) - Aggregate Company Assets|Total Business Assets CRGT|ATXI (Avenue Therapeutics, Inc.) - Company Total Assets|Company Assets Brainstorm Cell Therapeutics Inc. BCLI|Cumulative Company Assets CARA (Cara Therapeutics, Inc)|Company Total Assets Chromocell (CHRO)|Aggregate Company Assets Eliem Therapeutics Inc. ELYM|Aggregate Asset Value ITCI|LBPH - Aggregate Company Assets|Company Assets Marinus Pharmaceuticals Inc|NKGN: Company Total Assets|Cumulative Company Assets NeuroBo Pharma|SAGE (Sage Therapeutics, Inc.) - Company Total Assets|Company Assets synaptogen.com SNPX|Aggregate Company Assets Trevena (TRVN)|VIGL (vigilneuro.com) - Aggregate Asset Value|Company Total Assets WENA (Anew Medical)